Elevated hyaluronan and hyaluronan-mediated motility receptor are associated with biochemical failure in patients with intermediate-grade prostate tumors

Anthony E. Rizzardi, Rachel I Vogel, Joe Koopmeiners, Colleen L. Forster, Lauren O. Marston, Nikolaus K. Rosener, Natalia Akentieva, Matthew A Price, Greg Metzger, Christopher A Warlick, Jonathan C. Henriksen, Eva A. Turley, James B Mc Carthy, Stephen C. Schmechel

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

BACKGROUND The clinical course of prostate cancer (PCa) measured by biochemical failure (BF) after prostatectomy remains unpredictable in many patients, particularly in intermediate Gleason score (GS) 7 tumors, suggesting that identification of molecular mechanisms associated with aggressive PCa biology may be exploited for improved prognostication or therapy. Hyaluronan (HA) is a high molecular weight polyanionic carbohydrate produced by synthases (HAS1 through HAS3) and fragmented by oxidative/nitrosative stress and hyaluronidases (HYAL1 through HYAL4, SPAM1) common in PCa microenvironments. HA and HA fragments interact with receptors CD44 and hyaluronan-mediated motility receptor (HMMR), resulting in increased tumor aggressiveness in experimental PCa models. This study evaluated the association of HA-related molecules with BF after prostatectomy in GS7 tumors. METHODS Tissue microarrays were constructed from a 96-patient cohort. HA histochemistry and HAS2, HYAL1, CD44, CD44v6, and HMMR immunohistochemistry were quantified using digital pathology techniques. RESULTS HA in tumor-associated stroma and HMMR in malignant epithelium were significantly and marginally significantly associated with time to BF in univariate analysis, respectively. After adjusting for clinicopathologic features, both HA in tumor-associated stroma and HMMR in malignant epithelium were significantly associated with time to BF. Although not significantly associated with BF, HAS2 and HYAL1 positively correlated with HMMR in malignant epithelium. Cell culture assays demonstrated that HMMR bound native and fragmented HA, promoted HA uptake, and was required for a promigratory response to fragmented HA. CONCLUSIONS HA and HMMR are factors associated with time to BF in GS7 tumors, suggesting that increased HA synthesis and fragmentation within the tumor microenvironment stimulates aggressive PCa behavior through HA-HMMR signaling.

Original languageEnglish (US)
Pages (from-to)1800-1809
Number of pages10
JournalCancer
Volume120
Issue number12
DOIs
StatePublished - Jun 15 2014

Fingerprint

Hyaluronic Acid
Prostate
Neoplasms
Prostatic Neoplasms
Tumor Microenvironment
Epithelium
Prostatectomy
hyaluronan-mediated motility receptor
Hyaluronoglucosaminidase
Neoplasm Grading
Oxidative Stress
Cell Culture Techniques
Molecular Weight
Immunohistochemistry
Carbohydrates
Pathology

Keywords

  • biomarkers
  • digital pathology
  • hyaluronan
  • hyaluronan-mediated motility receptor
  • prostate cancer

Cite this

Elevated hyaluronan and hyaluronan-mediated motility receptor are associated with biochemical failure in patients with intermediate-grade prostate tumors. / Rizzardi, Anthony E.; Vogel, Rachel I; Koopmeiners, Joe; Forster, Colleen L.; Marston, Lauren O.; Rosener, Nikolaus K.; Akentieva, Natalia; Price, Matthew A; Metzger, Greg; Warlick, Christopher A; Henriksen, Jonathan C.; Turley, Eva A.; Mc Carthy, James B; Schmechel, Stephen C.

In: Cancer, Vol. 120, No. 12, 15.06.2014, p. 1800-1809.

Research output: Contribution to journalArticle

Rizzardi, Anthony E. ; Vogel, Rachel I ; Koopmeiners, Joe ; Forster, Colleen L. ; Marston, Lauren O. ; Rosener, Nikolaus K. ; Akentieva, Natalia ; Price, Matthew A ; Metzger, Greg ; Warlick, Christopher A ; Henriksen, Jonathan C. ; Turley, Eva A. ; Mc Carthy, James B ; Schmechel, Stephen C. / Elevated hyaluronan and hyaluronan-mediated motility receptor are associated with biochemical failure in patients with intermediate-grade prostate tumors. In: Cancer. 2014 ; Vol. 120, No. 12. pp. 1800-1809.
@article{be1c511922f74b6e8a909e5a42b7315f,
title = "Elevated hyaluronan and hyaluronan-mediated motility receptor are associated with biochemical failure in patients with intermediate-grade prostate tumors",
abstract = "BACKGROUND The clinical course of prostate cancer (PCa) measured by biochemical failure (BF) after prostatectomy remains unpredictable in many patients, particularly in intermediate Gleason score (GS) 7 tumors, suggesting that identification of molecular mechanisms associated with aggressive PCa biology may be exploited for improved prognostication or therapy. Hyaluronan (HA) is a high molecular weight polyanionic carbohydrate produced by synthases (HAS1 through HAS3) and fragmented by oxidative/nitrosative stress and hyaluronidases (HYAL1 through HYAL4, SPAM1) common in PCa microenvironments. HA and HA fragments interact with receptors CD44 and hyaluronan-mediated motility receptor (HMMR), resulting in increased tumor aggressiveness in experimental PCa models. This study evaluated the association of HA-related molecules with BF after prostatectomy in GS7 tumors. METHODS Tissue microarrays were constructed from a 96-patient cohort. HA histochemistry and HAS2, HYAL1, CD44, CD44v6, and HMMR immunohistochemistry were quantified using digital pathology techniques. RESULTS HA in tumor-associated stroma and HMMR in malignant epithelium were significantly and marginally significantly associated with time to BF in univariate analysis, respectively. After adjusting for clinicopathologic features, both HA in tumor-associated stroma and HMMR in malignant epithelium were significantly associated with time to BF. Although not significantly associated with BF, HAS2 and HYAL1 positively correlated with HMMR in malignant epithelium. Cell culture assays demonstrated that HMMR bound native and fragmented HA, promoted HA uptake, and was required for a promigratory response to fragmented HA. CONCLUSIONS HA and HMMR are factors associated with time to BF in GS7 tumors, suggesting that increased HA synthesis and fragmentation within the tumor microenvironment stimulates aggressive PCa behavior through HA-HMMR signaling.",
keywords = "biomarkers, digital pathology, hyaluronan, hyaluronan-mediated motility receptor, prostate cancer",
author = "Rizzardi, {Anthony E.} and Vogel, {Rachel I} and Joe Koopmeiners and Forster, {Colleen L.} and Marston, {Lauren O.} and Rosener, {Nikolaus K.} and Natalia Akentieva and Price, {Matthew A} and Greg Metzger and Warlick, {Christopher A} and Henriksen, {Jonathan C.} and Turley, {Eva A.} and {Mc Carthy}, {James B} and Schmechel, {Stephen C.}",
year = "2014",
month = "6",
day = "15",
doi = "10.1002/cncr.28646",
language = "English (US)",
volume = "120",
pages = "1800--1809",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "12",

}

TY - JOUR

T1 - Elevated hyaluronan and hyaluronan-mediated motility receptor are associated with biochemical failure in patients with intermediate-grade prostate tumors

AU - Rizzardi, Anthony E.

AU - Vogel, Rachel I

AU - Koopmeiners, Joe

AU - Forster, Colleen L.

AU - Marston, Lauren O.

AU - Rosener, Nikolaus K.

AU - Akentieva, Natalia

AU - Price, Matthew A

AU - Metzger, Greg

AU - Warlick, Christopher A

AU - Henriksen, Jonathan C.

AU - Turley, Eva A.

AU - Mc Carthy, James B

AU - Schmechel, Stephen C.

PY - 2014/6/15

Y1 - 2014/6/15

N2 - BACKGROUND The clinical course of prostate cancer (PCa) measured by biochemical failure (BF) after prostatectomy remains unpredictable in many patients, particularly in intermediate Gleason score (GS) 7 tumors, suggesting that identification of molecular mechanisms associated with aggressive PCa biology may be exploited for improved prognostication or therapy. Hyaluronan (HA) is a high molecular weight polyanionic carbohydrate produced by synthases (HAS1 through HAS3) and fragmented by oxidative/nitrosative stress and hyaluronidases (HYAL1 through HYAL4, SPAM1) common in PCa microenvironments. HA and HA fragments interact with receptors CD44 and hyaluronan-mediated motility receptor (HMMR), resulting in increased tumor aggressiveness in experimental PCa models. This study evaluated the association of HA-related molecules with BF after prostatectomy in GS7 tumors. METHODS Tissue microarrays were constructed from a 96-patient cohort. HA histochemistry and HAS2, HYAL1, CD44, CD44v6, and HMMR immunohistochemistry were quantified using digital pathology techniques. RESULTS HA in tumor-associated stroma and HMMR in malignant epithelium were significantly and marginally significantly associated with time to BF in univariate analysis, respectively. After adjusting for clinicopathologic features, both HA in tumor-associated stroma and HMMR in malignant epithelium were significantly associated with time to BF. Although not significantly associated with BF, HAS2 and HYAL1 positively correlated with HMMR in malignant epithelium. Cell culture assays demonstrated that HMMR bound native and fragmented HA, promoted HA uptake, and was required for a promigratory response to fragmented HA. CONCLUSIONS HA and HMMR are factors associated with time to BF in GS7 tumors, suggesting that increased HA synthesis and fragmentation within the tumor microenvironment stimulates aggressive PCa behavior through HA-HMMR signaling.

AB - BACKGROUND The clinical course of prostate cancer (PCa) measured by biochemical failure (BF) after prostatectomy remains unpredictable in many patients, particularly in intermediate Gleason score (GS) 7 tumors, suggesting that identification of molecular mechanisms associated with aggressive PCa biology may be exploited for improved prognostication or therapy. Hyaluronan (HA) is a high molecular weight polyanionic carbohydrate produced by synthases (HAS1 through HAS3) and fragmented by oxidative/nitrosative stress and hyaluronidases (HYAL1 through HYAL4, SPAM1) common in PCa microenvironments. HA and HA fragments interact with receptors CD44 and hyaluronan-mediated motility receptor (HMMR), resulting in increased tumor aggressiveness in experimental PCa models. This study evaluated the association of HA-related molecules with BF after prostatectomy in GS7 tumors. METHODS Tissue microarrays were constructed from a 96-patient cohort. HA histochemistry and HAS2, HYAL1, CD44, CD44v6, and HMMR immunohistochemistry were quantified using digital pathology techniques. RESULTS HA in tumor-associated stroma and HMMR in malignant epithelium were significantly and marginally significantly associated with time to BF in univariate analysis, respectively. After adjusting for clinicopathologic features, both HA in tumor-associated stroma and HMMR in malignant epithelium were significantly associated with time to BF. Although not significantly associated with BF, HAS2 and HYAL1 positively correlated with HMMR in malignant epithelium. Cell culture assays demonstrated that HMMR bound native and fragmented HA, promoted HA uptake, and was required for a promigratory response to fragmented HA. CONCLUSIONS HA and HMMR are factors associated with time to BF in GS7 tumors, suggesting that increased HA synthesis and fragmentation within the tumor microenvironment stimulates aggressive PCa behavior through HA-HMMR signaling.

KW - biomarkers

KW - digital pathology

KW - hyaluronan

KW - hyaluronan-mediated motility receptor

KW - prostate cancer

UR - http://www.scopus.com/inward/record.url?scp=84902155087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902155087&partnerID=8YFLogxK

U2 - 10.1002/cncr.28646

DO - 10.1002/cncr.28646

M3 - Article

VL - 120

SP - 1800

EP - 1809

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 12

ER -